WINNINGHAM RICK E (Chief Executive Officer) reported 1 transaction at THERAVANCE BIOPHARMA, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 6/25/2025ACC: 0001415889-25-018221
DirectorOfficer· Chief Executive Officer
Since Aug 2018
-20K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
20K disposed
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
−20K
Price / share
—
Trade value
—
% of position
1.1%
6/23/2025
1.75M→1.73M
Total
Net shares
−20K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 6/23/2025 | G · Gift | −20K | — | — | 1.1% | 1.75M | 1.73M |
| Total | −20K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Ordinary Shares
IndirectShares owned13.50K
Ordinary Shares
IndirectShares owned92.57K
Total
106.07K indirect106.07K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 13.50K | Indirect |
| Ordinary Shares | 92.57K | Indirect |
| Total | 106.07K | 106.07K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported